BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 25994830)

  • 1. Preservation of Glucagon-Like Peptide-1 Level Attenuates Angiotensin II-Induced Tissue Fibrosis by Altering AT1/AT 2 Receptor Expression and Angiotensin-Converting Enzyme 2 Activity in Rat Heart.
    Zhang LH; Pang XF; Bai F; Wang NP; Shah AI; McKallip RJ; Li XW; Wang X; Zhao ZQ
    Cardiovasc Drugs Ther; 2015 Jun; 29(3):243-55. PubMed ID: 25994830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conservation of glucagon like peptide-1 level with liraglutide and linagilptin protects the kidney against angiotensin II-induced tissue fibrosis in rats.
    Bai F; Zhang LH; Zhang WW; Zheng RH; Eskew JR; Bennett J; Wang NP; Bose HS; Zhao ZQ
    Eur J Pharmacol; 2020 Jan; 867():172844. PubMed ID: 31811859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuation of myocardial fibrosis with curcumin is mediated by modulating expression of angiotensin II AT1/AT2 receptors and ACE2 in rats.
    Pang XF; Zhang LH; Bai F; Wang NP; Garner RE; McKallip RJ; Zhao ZQ
    Drug Des Devel Ther; 2015; 9():6043-54. PubMed ID: 26648693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of angiotensin II-activated NOX4/NADPH oxidase and mitochondrial dysfunction by preserving glucagon-like peptide-1 attenuates myocardial fibrosis and hypertension.
    Banks TE; Rajapaksha M; Zhang LH; Bai F; Wang NP; Zhao ZQ
    Eur J Pharmacol; 2022 Jul; 927():175048. PubMed ID: 35644422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin II AT1 receptor alters ACE2 activity, eNOS expression and CD44-hyaluronan interaction in rats with hypertension and myocardial fibrosis.
    Bai F; Pang XF; Zhang LH; Wang NP; McKallip RJ; Garner RE; Zhao ZQ
    Life Sci; 2016 May; 153():141-52. PubMed ID: 27085217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postconditioning attenuates coronary perivascular and interstitial fibrosis through modulating angiotensin II receptors and angiotensin-converting enzyme 2 after myocardial infarction.
    Wang ZF; Wang NP; Harmouche S; Philip T; Pang XF; Bai F; Zhao ZQ
    J Surg Res; 2017 May; 211():178-190. PubMed ID: 28501115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liraglutide attenuates cardiac remodeling and improves heart function after abdominal aortic constriction through blocking angiotensin II type 1 receptor in rats.
    Zheng RH; Bai XJ; Zhang WW; Wang J; Bai F; Yan CP; James EA; Bose HS; Wang NP; Zhao ZQ
    Drug Des Devel Ther; 2019; 13():2745-2757. PubMed ID: 31496651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of linagliptin and liraglutide on glucose- and angiotensin II-induced collagen formation and cytoskeleton degradation in cardiac fibroblasts in vitro.
    Wang XW; Zhang FX; Yang F; Ding ZF; Agarwal N; Guo ZK; Mehta JL
    Acta Pharmacol Sin; 2016 Sep; 37(10):1349-1358. PubMed ID: 27498780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Edaravone inhibits pressure overload-induced cardiac fibrosis and dysfunction by reducing expression of angiotensin II AT1 receptor.
    Zhang WW; Bai F; Wang J; Zheng RH; Yang LW; James EA; Zhao ZQ
    Drug Des Devel Ther; 2017; 11():3019-3033. PubMed ID: 29081650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recruitment of macrophages from the spleen contributes to myocardial fibrosis and hypertension induced by angiotensin II.
    Wang NP; Erskine J; Zhang WW; Zheng RH; Zhang LH; Duron G; Gendreau J; Zhao ZQ
    J Renin Angiotensin Aldosterone Syst; 2017; 18(2):1470320317706653. PubMed ID: 28490219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II activates connective tissue growth factor and induces extracellular matrix changes involving Smad/activation and p38 mitogen-activated protein kinase signalling pathways in human dermal fibroblasts.
    Zhang GY; Li X; Yi CG; Pan H; He GD; Yu Q; Jiang LF; Xu WH; Li ZJ; Ding J; Lin DS; Gao WY
    Exp Dermatol; 2009 Nov; 18(11):947-53. PubMed ID: 19397700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrous tissue and angiotensin II.
    Sun Y; Ramires FJ; Zhou G; Ganjam VK; Weber KT
    J Mol Cell Cardiol; 1997 Aug; 29(8):2001-12. PubMed ID: 9281434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac protective effects of irbesartan via the PPAR-gamma signaling pathway in angiotensin-converting enzyme 2-deficient mice.
    Zhang ZZ; Shang QH; Jin HY; Song B; Oudit GY; Lu L; Zhou T; Xu YL; Gao PJ; Zhu DL; Penninger JM; Zhong JC
    J Transl Med; 2013 Sep; 11():229. PubMed ID: 24067190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-reactive protein promotes cardiac fibrosis and inflammation in angiotensin II-induced hypertensive cardiac disease.
    Zhang R; Zhang YY; Huang XR; Wu Y; Chung AC; Wu EX; Szalai AJ; Wong BC; Lau CP; Lan HY
    Hypertension; 2010 Apr; 55(4):953-60. PubMed ID: 20157054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of myocardial injury and collagen deposition following ischaemia-reperfusion by linagliptin and liraglutide, and both together.
    Wang X; Ding Z; Yang F; Dai Y; Chen P; Theus S; Singh S; Budhiraja M; Mehta JL
    Clin Sci (Lond); 2016 Aug; 130(15):1353-62. PubMed ID: 27129181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective role of ACE2-Ang-(1-7)-Mas in myocardial fibrosis by downregulating K
    Wang LP; Fan SJ; Li SM; Wang XJ; Gao JL; Yang XH
    Pflugers Arch; 2016 Nov; 468(11-12):2041-2051. PubMed ID: 27592222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steroidogenic acute regulatory protein/aldosterone synthase mediates angiotensin II-induced cardiac fibrosis and hypertrophy.
    Zhang WW; Zheng RH; Bai F; Sturdivant K; Wang NP; James EA; Bose HS; Zhao ZQ
    Mol Biol Rep; 2020 Feb; 47(2):1207-1222. PubMed ID: 31820314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue-specific regulation of ACE/ACE2 and AT1/AT2 receptor gene expression by oestrogen in apolipoprotein E/oestrogen receptor-alpha knock-out mice.
    Brosnihan KB; Hodgin JB; Smithies O; Maeda N; Gallagher P
    Exp Physiol; 2008 May; 93(5):658-64. PubMed ID: 18192335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasminogen activator inhibitor-1 expression is regulated by the angiotensin type 1 receptor in vivo.
    Nakamura S; Nakamura I; Ma L; Vaughan DE; Fogo AB
    Kidney Int; 2000 Jul; 58(1):251-9. PubMed ID: 10886570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucagon-like peptide-1 attenuates cardiac hypertrophy via the AngII/AT1R/ACE2 and AMPK/mTOR/p70S6K pathways.
    Wang J; Fan S; Xiong Q; Niu Y; Zhang X; Qin J; Shi Y; Zhang L
    Acta Biochim Biophys Sin (Shanghai); 2021 Aug; 53(9):1189-1197. PubMed ID: 34357376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.